tiprankstipranks
Trending News
More News >
Revelation Biosciences reports Q4 EPS ($4.98) vs ($133.64) last year
PremiumThe FlyRevelation Biosciences reports Q4 EPS ($4.98) vs ($133.64) last year
4M ago
Revelation doses first patient in PRIME Phase 1b clinical study
Premium
The Fly
Revelation doses first patient in PRIME Phase 1b clinical study
4M ago
Revelation Biosciences receives continued Nasdaq listing approval
Premium
The Fly
Revelation Biosciences receives continued Nasdaq listing approval
4M ago
Revelation Biosciences granted continued listing status on Nasdaq
PremiumThe FlyRevelation Biosciences granted continued listing status on Nasdaq
6M ago
Revelation Biosciences files to sell 14.22M shares of common stock for holders
Premium
The Fly
Revelation Biosciences files to sell 14.22M shares of common stock for holders
6M ago
Revelation Biosciences announces FDA acceptance of Gemini IND
Premium
The Fly
Revelation Biosciences announces FDA acceptance of Gemini IND
7M ago
Revelation Biosciences files $50M mixed securities shelf
PremiumThe FlyRevelation Biosciences files $50M mixed securities shelf
11M ago
Revelation announces Phase 1 study of Gemini met primary safety endpoint
Premium
The Fly
Revelation announces Phase 1 study of Gemini met primary safety endpoint
12M ago
Revelation Biosciences completes enrollment in Gemini study
Premium
The Fly
Revelation Biosciences completes enrollment in Gemini study
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100